GW Pharmaceuticals (GWP)
GWP Share PerformanceMore
|52 week high||0.0000|
|52 week low||0.0000|
|52 week change||0.0000 (0.00%)|
|4 week volume||0 27/01/18|
Latest News« previous» nextMore
29/09/2017 - 15:20 Interactive Investor
The annual AIM Awards are almost upon us, so former AIM writer of the year Andrew Hore names the small-cap compa...
02/06/2017 - 14:42 Interactive Investor
With AIM back near 1,000 for the first time in nine years, former AIM writer of the year Andrew Hore analyses the best ...
05/12/2016 - 07:00 RNS
RNS Number: 8466Q AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 05/12/2016 7:00am ORDINARY SHARES OF 0.1P EACH, FULLY PAID (30544...
01/12/2016 - 11:15 RNS
RNS Number: 7013Q GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting - Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional ind...
30/11/2016 - 13:15 StockMarketWire
GW Pharmaceuticals will announce its fourth quarter and year-end financial results for the period ending 30 September o...
30/11/2016 - 13:00 RNS
RNS Number: 4818Q GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and comm...
24/11/2016 - 07:30 RNS
RNS Number: 9985P GW Pharmaceuticals PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii GW Pharmaceuticals PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...
22/11/2016 - 14:28 StockMarketWire
GW Pharmaceuticals chief executive Justin Gover will present at the 28th annual Piper Jaffray Healthcare Conference at ...
Latest discussion posts More
“Just looking up to see when i first bought this share and started posting . I knew it must be before October 2012. I note nk 1999 asked if i was on it.... lol. If that is ...”▼
“Hi MischasMate, did you find a broker as I am in the same position. Thanks”▼
“I don't know for sure, but AJ Bell/YouInvest have been very good for me (low commission, helpful when it came to Open Offers for GKP and SXX) and I do know that I can trade ...”▼
Codes & Symbols
|Symbols||GWP, LSE:GWP, GWP.L, GWP:LN, LON:GWP, XLON:GWP|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment